Best Biotech Investors & VC Firms (2026 Rankings)

Top biotech VC firms in 2026. Find venture capital firms specializing in biotechnology, life sciences, and pharmaceutical startups.

50 firms ranked

30 investors

Top VC Firms for Biotech — Ranked by Portfolio

Rank	Firm	Team Members	Portfolio Investments
1	Gimv	11	888
2	Advantage Capital	10	830
3	Frazier Healthcare Partners	10	728
4	Inveready	7	614
5	Vertex Ventures SE Asia & India	7	553
6	TPG	6	513
7	Vivo Capital	6	490
8	OrbiMed	5	467
9	Seventure Partners	5	401
10	The Carlyle Group	3	279
11	Lerer Hippeau	3	272
12	Summit Partners	3	262
13	Andera Partners	3	250
14	Omnes	3	247
15	Menlo Ventures	3	238
16	ARCH Venture Partners	3	221
17	Hemisphere Ventures	2	187
18	Bethnal Green Ventures	2	183
19	8VC	2	175
20	Bain Capital	2	171
21	Polaris Partners	2	169
22	NGP Capital	2	162
23	Investinor	2	161
24	Osage University Partners (OUP)	2	159
25	Atlas Venture	2	157
26	Forbion	2	153
27	Abingworth	2	152
28	SV Health Investors	2	145
29	Foresite Capital	2	145
30	Syncsort	1	139
31	Getglue	1	131
32	Cambridge Innovation Capital	1	121
33	RRE Ventures	1	110
34	Khosla Ventures	1	106
35	Signatures Capital	1	104
36	Operation Masks	1	103
37	Agility Capital	1	102
38	Right Side Capital Management	1	101
39	Portugal Ventures	1	100
40	ACME Capital	1	96
41	FiveThirteen	1	96
42	Oxford Finance LLC	1	95
43	TextMarks	1	93
44	CrossLayer Capital	1	93
45	RBCx	1	92
46	Caffeinated Capital	1	92
47	Stanford University	1	91
48	Meritech Capital	1	91
49	Graphite Ventures	1	91
50	MaRS Discovery District	1	90

Top Individual Investors

Lonne Jaffe

Managing Director at Insight Partners

Syncsort

139 investments

Alex Iskold

Founder and Partner

Getglue

131 investments

Ian Lane

Partner

Cambridge Innovation Capital

121 investmentsCambridge, England

Raju Rishi

Board Member

RRE Ventures

110 investments

Samir Kaul

Founding General Partner

Khosla Ventures

106 investmentsMenlo Park, California

Bobby Yazdani

Founder & Managing Partner

Signatures Capital

104 investmentsSan Francisco, California

Jake Medwell

Co-Founder and Partner

Operation Masks

103 investmentsAustin, Texas

Daniel Corry

Chief Credit Officer Venture Lending and co founder

Agility Capital

102 investmentsSanta Barbara, California

Dave Lambert

Founder & Managing Director

Right Side Capital Management

101 investmentsSan Francisco, California

Kate Beardsley

Founding Partner, Hannah Grey

Lerer Hippeau

100 investmentsDenver, Colorado

Filomena Pastor

Director Engineering & Manufacturing BU

Portugal Ventures

100 investments

Jeff Rich

Chief Executive Officer

Hemisphere Ventures

99 investmentsDallas, Texas

Frequently Asked Questions

How is biotech VC different from tech VC?

Biotech VC requires deep scientific expertise, longer investment timelines (8-12+ years), higher capital requirements, and understanding of clinical trial phases, FDA approval, and IP portfolios.

What stage do biotech VCs typically invest?

Biotech VCs invest across stages but many specialize — some focus on platform-stage (preclinical), others on clinical-stage companies with Phase I/II data, and some on late-stage near-approval assets.

How much funding do biotech startups need?

Biotech startups often need $50M-$200M+ to reach market, with seed rounds of $5-15M, Series A of $30-80M, and significant later-stage funding for clinical trials.

Explore More Rankings

Early-Stage VC Firms Seed Stage VC Firms Series A VC Firms Pre-Seed Investors VC Firms for SaaS VC Firms for Fintech

Get Full Access